MolinskyRL, GagliaJ, ZhangY, et al.Real-world total daily insulin dose in over 14,000 young individuals with type 1 diabetes in the United States. Diabetes Technol Ther2026:15209156261447653; doi: 10.1177/15209156261447653
2.
American Diabetes Association Professional Practice Committee. Diabetes technology: Standards of Care in Diabetes—2025. Diabetes Care2025;48(Suppl 1):S146–S166; doi: 10.2337/dc25-S007
3.
de VisserHS, WaraichS, ChhabraM, et al.; TEAM Trial Patient Coresearchers. Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: A systematic review and meta-analysis. JAMA Pediatr2025;179(11):1162–1171; doi: 10.1001/jamapediatrics.2025.2740
4.
SantovaA, de BockM, LanzingerS, et al.; SWEET Study Group. Global inequities in diabetes technology and insulin access and glycemic outcomes. JAMA Netw Open2025;8(8):e2528933; doi: 10.1001/jamanetworkopen.2025.28933
5.
SabooB, GargS, BergenstalRM, et al.; Call-to-Action Coalition. A call-to-action to eliminate barriers to accessing automated insulin delivery systems for people with type 1 diabetes. Diabetes Technol Ther2025;27(3):147–151; doi: 10.1089/dia.2025.0028
